Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) combined with R-CHOP for the treatment of diffuse large B-cell lymphoma 2024-04-30 20:55
A Potential First-In-Class Drug: CDE Approved Single-Arm Pivotal Clinical Study of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs 2024-04-30 20:16
I-MAB Filed 2023 Annual Report on Form 20-F 2024-04-30 19:00
HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update 2024-04-30 19:00
111 to Announce First Quarter 2024 Unaudited Financial Results on May 23, 2024 - Conference Call to Follow 2024-04-30 14:30
WuXi Biologics Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment 2024-04-30 10:55
Waterdrop Inc. Releases 2023 Annual Report: Sustained Profitability and Impressive Growth in Innovative Businesses 2024-04-30 10:39
China Jo-Jo Drugstores Announces $1.53 Million Registered Direct Offering 2024-04-29 21:00
Medit launches the revolutionary i900, an intraoral scanning system set to redefine the scanning experience for dental clinics worldwide 2024-04-29 21:00
Hurom Takes Global Action to Protect Juicer Patents 2024-04-29 21:00
CARsgen Submitted Responses to FDA Observations 2024-04-29 20:50
Laekna Releases 2023 ESG Report 2024-04-29 20:30
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule 2024-04-29 20:00
Technoderma Medicines Advances TDM-180935 Atopic Dermatitis Clinical Program with Phase 2 Trial 2024-04-29 20:00
Prota Therapeutics' CEO Mimi Tang honoured at BioMelbourne Network's Women in Leadership Awards 2024 2024-04-29 19:25
WuXi AppTec Achieved First Quarter 2024 Target Despite External Challenges, Maintaining Stable Operations 2024-04-29 19:00
DP Technology DevDay 2024 Showcases Large Science Models and Announces Open Science Initiative 2024-04-29 15:31
OBiO Technology will showcase at American Society of Gene & Cell Therapy 2024-04-29 00:00
MGI Tech opens Customer Experience Center in Brazil to contribute to the advancement of genomics in Latin America 2024-04-28 17:54
Novel T-cell engager, CDH17 X CD3 cabotamig (ARB202) continues to explore dosing in patients with advanced gastrointestinal cancers 2024-04-26 21:00
1 2 3 4 5 779